U.S. Transportation Stock News

Investors may be wondering whether RingCentral's current share price reflects its true worth, or if the recent price action has left it mispriced in either direction. The stock last closed at US$45.39, with returns of 12.9% over 7 days, 19.5% over 30 days, 64.5% year to date, 70.5% over 1 year, 58.2% over 3 years, and an 80.9% decline over 5 years. This presents a mixed picture of strong rebounds alongside longer term losses. Recent coverage has focused on RingCentral's position as a...

Kyndryl Holdings recently reported fourth-quarter 2026 results showing largely unchanged revenue of US$3.77 billion but a sharp drop in net income to US$17 million, while also completing a share repurchase of 14,300,000 shares for US$398 million under its November 2024 buyback program. A day later, the Arizona Department of Transportation Motor Vehicle Division announced an expanded collaboration with Kyndryl to further modernize its statewide digital services, highlighting Kyndryl’s growing...

If you are wondering whether PTC at around US$147.65 is priced attractively, this article walks through what the current valuation signals might mean for you. The stock has seen an 8.3% move over the last 7 days and 2.6% over the past month, but is still showing a 13.2% decline year to date and a 10.4% decline over the last year, which may catch the eye of investors weighing potential opportunity against recent sentiment. Recent coverage of PTC has focused on its role as a US software...

Curtiss-Wright recently reported its first-quarter 2026 results, with revenue of US$913.69 million and net income of US$128.19 million, alongside completing a multi-year US$1.38 billion share repurchase program covering 17.52% of its shares. The company also advanced its role in next-generation nuclear technology by moving into prototype manufacturing of key systems for X-energy’s Xe-100 reactor, underlining its exposure to the emerging advanced nuclear market. We’ll now examine how the...

Nuvation Bio has reported that in the first quarter of 2026 it generated US$83.23 million in revenue and US$5.4 million in net income, while the FDA has accepted a supplemental New Drug Application to update IBTROZI’s label with longer-term data in advanced ROS1-positive non-small cell lung cancer. These developments, alongside IBTROZI’s addition to NCCN guidelines for CNS cancers and strong intracranial response data, reinforce the company’s emerging role in treating ROS1-positive lung...

Wondering if Scholar Rock Holding at around US$46.45 is giving you fair value or a potential opportunity? This article walks through the key numbers in plain language so you can judge for yourself. The stock has seen mixed recent returns, with a 0.3% decline over the last 7 days and a 6.9% decline over the last month, alongside gains of 8.5% year to date, 49.9% over 1 year and a very large 3 year return, plus a 63.3% gain over 5 years. These moves have come as investors weigh ongoing...

T-Mobile US recently reported past first-quarter 2026 results showing revenue of US$23,107 million and net income of US$2,504 million, while also filing an omnibus shelf registration covering common and preferred stock, debt and other securities. The company is intensifying its network-resilience and broadband push through AI-powered emergency connectivity tools, expanded satellite services with Starlink, and new fiber joint ventures that could broaden its high-speed internet footprint to...

Niagen Bioscience (NAGE) is back on investors’ radar after reporting Q1 2026 results that exceeded consensus estimates, alongside the launch of its Niagen Plus telehealth platform and at-home prescription injection kits. See our latest analysis for Niagen Bioscience. Despite the upbeat Q1 report and new Niagen Plus initiatives, the stock’s recent momentum has been weak, with a 30 day share price return of a 6.26% decline and a year to date share price return of a 32.96% decline. The 3 year...

Investors may be wondering whether Evercore, at around US$331 per share, still offers value or whether most of the easy gains are already behind it. The stock has delivered a 3.1% move over the last week and 7.9% over the past month, while year to date it is at a 5.7% decline against a 54.6% return over the last year, a 225.1% return over three years, and 154.1% over five years. Recent coverage has focused on Evercore's role in major advisory mandates and its position within capital markets...

Wondering if Hercules Capital's share price really reflects what you are getting for your money? This breakdown walks through what the current market price might be missing or already pricing in. Recently, the stock closed at US$16.40, with returns of 2.2% over 7 days, 8.5% over 30 days, 4.0% over 1 year and 67.6% over both 3 and 5 years, while the year to date return sits at a 13.0% decline. These moves sit against a backdrop of ongoing interest in income focused business development...

In early May 2026, Restaurant Brands International reported first-quarter 2026 results with revenue rising to US$2,264 million and net income reaching US$338 million, while also completing a US$59.86 million share repurchase tranche and affirming a quarterly dividend of US$0.65 per share. Beneath the headline beat, investors focused on the contrasting performance across brands, with strong Burger King momentum offset by weaker Popeyes results and higher cost concerns in the Restaurant...

Praxis Precision Medicines (NasdaqGS:PRAX) reported that the FDA accepted New Drug Applications for ulixacaltamide and relutrigine. The company is preparing for potential U.S. launches following these NDA acceptances. Praxis also highlighted clinical progress for elsunersen, adding to momentum across its late-stage pipeline. For readers tracking central nervous system drug developers, Praxis sits at an important point in its evolution, with ulixacaltamide and relutrigine moving into formal...

Why Mondelez International (MDLZ) Is Back on Investors’ Radar Mondelez International (MDLZ) has attracted fresh attention after recent share moves, with the stock showing mixed short term returns and a modest gain over the past month. This has prompted closer inspection of its fundamentals. See our latest analysis for Mondelez International. At a share price of $61.31, Mondelez’s recent 30-day share price return of 6.61% contrasts with a weaker 1-year total shareholder return of a 5.75%...

If you are wondering whether Gulfport Energy, at a last close of US$178.80, is attractively priced or if the easy gains are behind it, this article breaks down what the current share price might be implying about the stock's value. The stock has seen a 7.1% decline over the last week, a 13.9% decline over the last month, and a 13.3% decline year to date, set against a 94.6% return over the last 3 years and a 5.0% decline over the last year. Recent coverage has focused on Gulfport Energy's...

EIR Healthcare recently announced a partnership with MillerKnoll to integrate casework, furniture, and interior solutions directly into factory-built healthcare modules, aiming to deliver fully furnished, quality-checked clinics from day one. This move embeds MillerKnoll into an emerging offsite healthcare construction model that targets faster, more reliable delivery of behavioral health facilities funded by large public programs. We’ll now examine how embedding MillerKnoll’s solutions into...

Wondering if Adient at around US$21.86 is offering genuine value or just looks cheap on the surface? This article breaks down what that price might really mean for you. The stock has returned 3.8% over the last 7 days, 9.2% over the last 30 days, 14.8% year to date and 58.8% over the last year. However, the 3 year and 5 year returns of 38.7% and 53.9% declines show a much bumpier longer term picture. Recent coverage has focused on Adient's position in auto components and how investors are...

Sunstone Hotel Investors (SHO) caught investor attention after raising its 2026 net income guidance and reporting first quarter results that showed higher revenue, net income and earnings per share compared with a year earlier. See our latest analysis for Sunstone Hotel Investors. The raised 2026 guidance and stronger first quarter figures have coincided with a 15.0% 1 month share price return and a 13.4% year to date share price return. The 1 year total shareholder return of 28.7% points to...

This article explores whether Dollar General's current share price still offers value after a mixed few years, and walks through what the current market price might be implying about the stock. The stock recently closed at US$116.47, with returns of 0.5% over 7 days, a 3.9% decline over 30 days, a 14.9% decline year to date and a 29.2% gain over 1 year, compared with 3 year and 5 year returns of 42.9% and 38.6% declines respectively. Recent coverage has highlighted how investors are...

Why MSC Industrial Direct Stock Is Back in Focus MSC Industrial Direct (MSM) is back on investors’ radar after recent earnings and revenue shortfalls were followed by analyst upgrades linked to cost-cutting efforts, pricing changes, and a strong run in the share price. See our latest analysis for MSC Industrial Direct. At around $104.31 per share, MSC Industrial Direct is trading close to its recent 52 week high, with a 15% 30 day share price return and a 42.7% 1 year total shareholder...

If you are wondering whether Starbucks at around US$104 per share still offers value, it helps to step back and look at what the recent price action and fundamentals are really telling you. Over the last week the stock recorded a 1% decline, but over 30 days it returned 9.5% and year to date it is at 24.2%, with a 30.4% return over the past year that may be reshaping how investors think about its risk and reward profile. These moves sit against a backdrop where Starbucks continues to feature...

Investors may be wondering whether Marsh & McLennan Companies is starting to offer better value, or if the current share price already reflects its strengths. The stock last closed at US$166.03, with returns of a 1% decline over 7 days, a 3.8% decline over 30 days, a 9% decline year to date, a 25.9% decline over 1 year, and a 3.4% decline over 3 years, compared with a 33.1% gain over 5 years. Recent market attention has focused on how Marsh & McLennan Companies is positioned within the...

For investors considering whether Cardinal Health's share price still offers value after a strong multi year run, this article explains what the current market price could be implying about the stock. The stock last closed at US$185.28, with returns of 27.2% over 1 year, 129.5% over 3 years and 270.6% over 5 years. This comes despite 7 day, 30 day and year to date returns of 3.9%, 12.9% and 9.9% declines respectively. Recent coverage around Cardinal Health has focused on its role as a major...

Why Element Solutions (ESI) is in focus after its latest earnings Element Solutions (ESI) recently reported first quarter results, with sales of US$840 million versus US$593.7 million a year earlier, while net income was US$55.9 million compared with US$98 million. See our latest analysis for Element Solutions. Even with a 4.45% 1-day share price decline to US$42.27 after earnings and a modest 7-day pullback, Element Solutions still sits on a 22.17% 1-month share price return and a 100.61%...

Recent performance snapshot and why the stock is on investors’ radar Oceaneering International (OII) has drawn attention after a mixed stretch in its share performance, with a 1 day return of a 1.3% decline and a 7 day move of a 2.6% decline as investors reassess recent gains. See our latest analysis for Oceaneering International. While the recent pullback, including a 2.4% 30 day share price return decline from the latest close of $36.58, hints at cooling short term momentum, the 47.2%...